Nodule Science Revenue

About Nodule Science

Nodule Science has a team of physicians and navigators to assist in developing your lung nodule program; provide a thorough assessment of your existing program and resources; meet with key stakeholders including navigators, pulmonologists, radiologists, thoracic surgeons, thoracic oncology, and administration; provide an economic assessment of your current program and demonstrate ROI; facilitate relationships with key vendors and KOLs Why is lung cancer the number one cancer killer in the world? Broadly, it is due to interval scanning and follow-up...kicking the can down the investigatory road! Nodule Science exists to push lung cancer care into a new paradigm using a proactive approach to lung cancer screening and incidental nodule management. Harnessing the power of artificial intelligence (AI), Nodule Science addresses lung cancer and nodule care in a 3 part approach: Detection, Stratification, and Triage/ Tracking. Currently, manual or software-based detection and triage alone have not brought enough actionable information to accelerate the care of patients and this has led to a disorganized and poorly resourced approach to lung nodules. Moreover, lung cancer/ nodule navigators have become overwhelmed often resorting to homemade spreadsheets to assist, leading to burnout and turnover of a valuable, key resource. Key to this dilemma is nodule risk stratification. RevealDX has developed an AI software analysis of lung nodules that has been clinically validated to predict the likelihood of malignancy (mSI), predicting lung cancer in up to 50% of known malignancies on average of 16 months before they are currently detected. This new paradigm, when applied to a structured LN program, generates a simple, objective number that not only assesses the likelihood of malignancy, but becomes the risk based foundation metric to track and triage patients, generate automatic patient journeys, and simplify the workflow of LN navigators.

View contact profiles from Nodule Science